Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

N Germain,M Romano,S Aballéa,M Toumi,Na Hawken

doi:10.1016/j.jval.2017.08.1507

Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

N Germain, M Romano + Show 3 more

Open Access

https://doi.org/10.1016/j.jval.2017.08.1507

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Oct 1, 2017
License type: publisher-specific-oa

Affiliation: Creativ-Ceutical (France), ALK-Abelló (Denmark)

#Allergic Rhinitis #Quality Of Life + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

Full Text